Xencor, Inc. , a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today announced the appointment of Bart Cornelissen.
In his role as the new executive director of the Los Angeles chapter of statewide industry resource and advocacy group Biocom California, Dan Gober’s goal is to provide a boost to the region’s bioscience industry and its local microclusters.
MorphoSys (OTCMKTS:MPSYF – Get Free Report) and BioRestorative Therapies (OTCMKTS:BRTX – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk and analyst recommendations. Insider and Institutional Ownership 69.4% of BioRestorative Therapies shares […]
Xencor (NASDAQ:XNCR) Lifted to "Hold" at StockNews.com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.